Clinical Trial Update: A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS [Phase 2]

View source ↗

Summary

Phase IIb multicenter, multinational trial of PrimeC in amyotrophic lateral sclerosis has completed and evaluated safety, tolerability and efficacy, with an ope…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• PrimeC

Snippet

Sponsor: NeuroSense Therapeutics Ltd. | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 2 | Status: COMPLETED